CA2917443A1 - Acoustic based drug delivery monitor - Google Patents
Acoustic based drug delivery monitor Download PDFInfo
- Publication number
- CA2917443A1 CA2917443A1 CA2917443A CA2917443A CA2917443A1 CA 2917443 A1 CA2917443 A1 CA 2917443A1 CA 2917443 A CA2917443 A CA 2917443A CA 2917443 A CA2917443 A CA 2917443A CA 2917443 A1 CA2917443 A1 CA 2917443A1
- Authority
- CA
- Canada
- Prior art keywords
- drug delivery
- monitor
- monitoring system
- delivery device
- event
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000012377 drug delivery Methods 0.000 title claims abstract description 169
- 238000012544 monitoring process Methods 0.000 claims abstract description 104
- 229940090047 auto-injector Drugs 0.000 claims description 13
- 238000003860 storage Methods 0.000 claims description 13
- 230000009471 action Effects 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 6
- 230000000007 visual effect Effects 0.000 claims description 5
- 239000000969 carrier Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 60
- 229940079593 drug Drugs 0.000 abstract description 54
- 238000012384 transportation and delivery Methods 0.000 description 61
- 239000000853 adhesive Substances 0.000 description 56
- 230000001070 adhesive effect Effects 0.000 description 56
- 238000000034 method Methods 0.000 description 36
- 238000012549 training Methods 0.000 description 21
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 230000009325 pulmonary function Effects 0.000 description 15
- 238000002347 injection Methods 0.000 description 13
- 239000007924 injection Substances 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 239000002552 dosage form Substances 0.000 description 10
- 230000003434 inspiratory effect Effects 0.000 description 9
- 208000006673 asthma Diseases 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000013011 mating Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241001025261 Neoraja caerulea Species 0.000 description 4
- 239000012790 adhesive layer Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000004199 lung function Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000005236 sound signal Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000001960 triggered effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 229940126534 drug product Drugs 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000013125 spirometry Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000037317 transdermal delivery Effects 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 229940112141 dry powder inhaler Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000012768 mass vaccination Methods 0.000 description 2
- 229940090048 pen injector Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000009613 pulmonary function test Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000037874 Asthma exacerbation Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010056438 Growth hormone deficiency Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010057362 Underdose Diseases 0.000 description 1
- YYAZJTUGSQOFHG-IAVNQIGZSA-N [(6s,8s,10s,11s,13s,14s,16r,17r)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate;2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]eth Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)C1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O YYAZJTUGSQOFHG-IAVNQIGZSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000024716 acute asthma Diseases 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 229940090167 advair Drugs 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 229960004538 alprazolam Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 229940127560 insulin pen Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011545 laboratory measurement Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940125386 long-acting bronchodilator Drugs 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229940071648 metered dose inhaler Drugs 0.000 description 1
- 229960002803 methaqualone Drugs 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 229960000470 omalizumab Drugs 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 238000012950 reanalysis Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- -1 troches Substances 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
- G01F22/00—Methods or apparatus for measuring volume of fluids or fluent solid material, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0418—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with electronic history memory
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0427—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system
- A61J7/0436—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers with direct interaction with a dispensing or delivery system resulting from removing a drug from, or opening, a container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0463—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers for multiple patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/008—Electronic counters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/0081—Locking means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/27—General characteristics of the apparatus preventing use
- A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3375—Acoustical, e.g. ultrasonic, measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3569—Range sublocal, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Primary Health Care (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Fluid Mechanics (AREA)
- General Physics & Mathematics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845670P | 2013-07-12 | 2013-07-12 | |
| US61/845,670 | 2013-07-12 | ||
| PCT/US2014/046367 WO2015006701A2 (en) | 2013-07-12 | 2014-07-11 | Acoustic based drug delivery monitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2917443A1 true CA2917443A1 (en) | 2015-01-15 |
Family
ID=52280732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2917443A Abandoned CA2917443A1 (en) | 2013-07-12 | 2014-07-11 | Acoustic based drug delivery monitor |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160166766A1 (enExample) |
| EP (1) | EP3019081A4 (enExample) |
| JP (1) | JP2016526471A (enExample) |
| AU (1) | AU2014287059A1 (enExample) |
| CA (1) | CA2917443A1 (enExample) |
| WO (1) | WO2015006701A2 (enExample) |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5479465B2 (ja) | 2008-06-20 | 2014-04-23 | マンカインド コーポレイション | 吸入努力をリアルタイムにプロファイルする対話式機器および方法 |
| US9767708B2 (en) | 2012-04-04 | 2017-09-19 | Genia Medical Inc. | Medicament training device and system |
| US10283014B2 (en) | 2012-04-04 | 2019-05-07 | Jbcb Holdings, Llc | Smart packaging and display system |
| EP4400921A3 (en) | 2012-06-25 | 2024-10-09 | Gecko Health Innovations, Inc. | Devices, systems, and methods for adherence monitoring and patient interaction |
| WO2016049066A1 (en) * | 2014-09-23 | 2016-03-31 | Oscillari Llc | Vibration sensor based drug delivery monitor |
| AU2014312428B2 (en) | 2013-08-28 | 2018-10-11 | Gecko Health Innovations, Inc. | Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers |
| DK3038685T3 (da) * | 2013-08-30 | 2021-01-04 | Adherium Nz Ltd | Overvågningsmonitor til en medikamentinhalator |
| US11424017B2 (en) | 2013-10-19 | 2022-08-23 | Aptargroup, Inc. | Respiratory system and method that monitors medication flow |
| US10019555B2 (en) | 2013-10-19 | 2018-07-10 | Cohero Health, Inc. | Interactive respiratory device usage tracking system |
| CN106132465B (zh) * | 2014-03-25 | 2019-09-24 | 皇家飞利浦有限公司 | 具有用于吸气流动的检测的两个麦克风的吸入器 |
| WO2015154865A2 (en) * | 2014-04-07 | 2015-10-15 | Boehringer Ingelheim International Gmbh | Inhalation training device and system for practicing of an inhalation process of a patient |
| HUE049888T2 (hu) * | 2014-04-07 | 2020-11-30 | Boehringer Ingelheim Int | Eljárás, elektronikus szerkezet, inhalációs gyakorló rendszer egy paciens inhalációs folyamatának gyakorlásához és/vagy kontrolálásához |
| BR112017003868A2 (pt) | 2014-08-28 | 2018-06-26 | Microdose Therapeutx, Inc. | módulo de monitoração de conformidade para inaladores acionados pela respiração, inaladores que o contenham, método de utilização e programa de computador para execução do método. |
| IL288910B2 (en) | 2014-08-28 | 2025-03-01 | Norton Waterford Ltd | Compliance monitoring module for an inhaler |
| KR20170047321A (ko) | 2014-08-28 | 2017-05-04 | 마이크로도스 테라퓨특스, 인코포레이티드 | 소형 압력 센서 활성화를 동반하는 주기적 건조 분말 흡입기 |
| US11033694B2 (en) | 2014-09-22 | 2021-06-15 | Koninklijke Philips N.V. | Inhaler with orientation sensor |
| DK3209355T3 (da) | 2014-10-21 | 2020-07-06 | Sanofi Aventis Deutschland | Registrering af dosisdata fra lægemiddelinjektionsanordninger ved anvendelse af optisk karaktergenkendelse (ocr) |
| JP6822950B2 (ja) | 2014-10-21 | 2021-01-27 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 光学文字認識を使用した薬物注射デバイスからの用量データの記録 |
| GB201420039D0 (en) | 2014-11-11 | 2014-12-24 | Teva Uk Ltd | System for training a user in administering a medicament |
| US10058661B2 (en) | 2014-12-04 | 2018-08-28 | Norton (Waterford) Limited | Inhalation monitoring system and method |
| GB2537150A (en) * | 2015-04-09 | 2016-10-12 | Univ Manchester | Inhaler spacer |
| GB201514372D0 (en) * | 2015-08-13 | 2015-09-30 | Selex Es Ltd | Monitoring systems and methods |
| CN105056355B (zh) * | 2015-09-02 | 2018-01-02 | 广州医科大学附属第一医院 | 一种带数据统计及上传功能的口腔给药装置 |
| US9899035B2 (en) * | 2015-11-04 | 2018-02-20 | Ioannis Kakadiaris | Systems for and methods of intelligent acoustic monitoring |
| US10894142B2 (en) | 2016-03-24 | 2021-01-19 | Trudell Medical International | Respiratory care system with electronic indicator |
| JP2019516485A (ja) * | 2016-05-19 | 2019-06-20 | マンカインド コーポレイション | 吸入を検出および監視するための機器、システム、および方法 |
| WO2017199215A1 (en) | 2016-05-19 | 2017-11-23 | Trudell Medical International | Smart valved holding chamber |
| EP3481476B1 (en) | 2016-07-08 | 2021-09-08 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| CN110022922B (zh) | 2016-10-03 | 2022-10-28 | 乔吉·内瓦尔·莫尔·内托 | 递送咖啡衍生挥发物的装置、系统和方法 |
| US10483599B2 (en) * | 2016-10-05 | 2019-11-19 | Scosche Industries, Inc. | Magnetically attached battery pack with audio interface |
| ES2884802T3 (es) | 2016-11-18 | 2021-12-13 | Norton Waterford Ltd | Dispositivo de administración de fármacos con componentes electrónicos |
| CN110177591B (zh) | 2016-11-18 | 2021-11-19 | 诺顿（沃特福特）有限公司 | 吸入器 |
| JP7093353B2 (ja) | 2016-12-09 | 2022-06-29 | トゥルーデル メディカル インターナショナル | スマートネブライザ |
| US9731103B1 (en) | 2017-01-13 | 2017-08-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration devices and associated systems and methods |
| EP3381493B1 (en) | 2017-03-30 | 2023-06-07 | Ypsomed AG | Electronic unit for injection devices |
| EP3621680A1 (en) | 2017-05-09 | 2020-03-18 | Novo Nordisk A/S | Drug delivery device with sound transducer |
| US10792226B2 (en) | 2017-06-07 | 2020-10-06 | Berkshire Biomedical, LLC | Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices |
| US10522252B2 (en) | 2017-06-16 | 2019-12-31 | Carefusion 303, Inc. | Opioid management system |
| WO2018233794A1 (en) * | 2017-06-23 | 2018-12-27 | Københavns Universitet | Inhaler with acoustic flow monitoring |
| EP3655064A1 (en) | 2017-07-18 | 2020-05-27 | Becton, Dickinson and Company | Administration system, delivery device, and notification device for communicating status of a medical device |
| US10989803B1 (en) | 2017-08-21 | 2021-04-27 | Massachusetts Institute Of Technology | Security protocol for motion tracking systems |
| GB2570439A (en) * | 2017-12-13 | 2019-07-31 | British American Tobacco Investments Ltd | Method and apparatus for analysing user interaction |
| CA3086890A1 (en) | 2018-01-04 | 2019-07-11 | Trudell Medical International | Smart oscillating positive expiratory pressure device |
| US11081220B2 (en) | 2018-02-02 | 2021-08-03 | Carefusion 303, Inc. | System and method for dispensing medication |
| US10441509B2 (en) | 2018-03-16 | 2019-10-15 | Berkshire Biomedical, LLC | Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods |
| US11040243B2 (en) * | 2018-03-23 | 2021-06-22 | Breathe With B, Inc. | Breathing device |
| EP3788634B1 (en) | 2018-05-04 | 2024-06-26 | CareFusion 303, Inc. | Peer community based anomalous behavior detection |
| EP3572107A1 (en) * | 2018-05-22 | 2019-11-27 | Tecpharma Licensing AG | Click event identification in delivery devices |
| US11395890B2 (en) | 2018-06-04 | 2022-07-26 | Trudell Medical International | Smart valved holding chamber |
| WO2019236759A1 (en) | 2018-06-06 | 2019-12-12 | Masimo Corporation | Opioid overdose monitoring |
| US12097043B2 (en) | 2018-06-06 | 2024-09-24 | Masimo Corporation | Locating a locally stored medication |
| GB201809559D0 (en) * | 2018-06-09 | 2018-07-25 | Smiths Medical International Ltd | Respiratory therapy apparatus and methods |
| CA3105148A1 (en) * | 2018-08-16 | 2020-02-20 | Boehringer Ingelheim International Gmbh | System for monitoring the dispensing of an administrable substance, protecting element and dispensing device |
| CN112638455B (zh) * | 2018-08-28 | 2023-08-18 | 万通集团公司 | 检测药物流的呼吸系统和方法 |
| US11464410B2 (en) | 2018-10-12 | 2022-10-11 | Masimo Corporation | Medical systems and methods |
| CN109461487B (zh) * | 2018-10-29 | 2020-11-17 | 深圳麦科田生物医疗技术有限公司 | 一种pca输注装置及提前解除锁定的方法、装置及存储介质 |
| EP3883459A1 (en) * | 2018-11-20 | 2021-09-29 | Massachusetts Institute of Technology | Therapy monitoring system |
| WO2020146407A1 (en) | 2019-01-07 | 2020-07-16 | Carefusion 303, Inc. | Machine learning based safety controller |
| US11984212B2 (en) | 2019-01-10 | 2024-05-14 | Carefusion 303, Inc. | System for monitoring dose pattern and patient response |
| WO2020150596A1 (en) * | 2019-01-18 | 2020-07-23 | Carefusion 303, Inc. | Medication tracking system |
| WO2020222148A1 (en) | 2019-04-30 | 2020-11-05 | Norton (Waterford) Limited | Inhaler system |
| US11419995B2 (en) | 2019-04-30 | 2022-08-23 | Norton (Waterford) Limited | Inhaler system |
| AU2020278126B2 (en) | 2019-05-17 | 2025-07-03 | Norton (Waterford) Limited | Drug delivery device with electronics |
| US10729860B1 (en) | 2019-05-22 | 2020-08-04 | Berkshire Biomedical, LLC | Computerized oral prescription administration for securely dispensing a medication and associated systems and methods |
| US11195270B2 (en) * | 2019-07-19 | 2021-12-07 | Becton Dickinson Rowa Germany Gmbh | Measuring and verifying drug portions |
| AU2020338979B2 (en) | 2019-08-27 | 2025-09-25 | Trudell Medical International Inc. | Smart oscillating positive expiratory pressure device |
| US12437862B2 (en) | 2019-09-27 | 2025-10-07 | Carefusion 303, Inc. | Rare instance analytics for diversion detection |
| AU2020399299A1 (en) | 2019-12-10 | 2022-06-16 | Trudell Medical International Inc. | Integrated dose counter |
| US20230016406A1 (en) * | 2019-12-12 | 2023-01-19 | Sanofi | Medical Device Comprising an Alarm Generator Taking Into Account Environmental Signals |
| CN115380299A (zh) | 2020-02-24 | 2022-11-22 | 康尔福盛303公司 | 模块化见证装置 |
| JP7737391B2 (ja) | 2020-03-20 | 2025-09-10 | マシモ・コーポレイション | 非侵襲的な体温測定のためのウェアラブルデバイス |
| EP4149407B1 (en) | 2020-05-14 | 2025-02-05 | CareFusion 303, Inc. | Wasting station for medications |
| CA3182942A1 (en) * | 2020-05-22 | 2021-11-25 | Baxter International Inc | Infusion pump with accelerometer controlled surface temperature |
| CN112466473A (zh) * | 2020-09-28 | 2021-03-09 | 北京左医科技有限公司 | 新发传染病自动预警方法及系统 |
| CN112604084B (zh) * | 2020-12-07 | 2023-04-07 | 杭州慧钥医疗器械科技有限公司 | 音频数据的采集方法、装置、设备及可读存储介质 |
| US12482554B2 (en) | 2021-02-26 | 2025-11-25 | Carefusion 303, Inc. | Dosage normalization for detection of anomalous behavior |
| IL305701A (en) * | 2021-03-31 | 2023-11-01 | Amgen Inc | A sound-detection-based injection time measurement system for drug delivery devices |
| CN113159210B (zh) * | 2021-04-30 | 2022-11-08 | 电子科技大学 | 物体剩余量检测模型训练方法、检测方法、系统及设备及存储介质 |
| WO2022249445A1 (ja) * | 2021-05-28 | 2022-12-01 | 日本たばこ産業株式会社 | 情報処理方法、情報処理端末、及び情報処理システム |
| CN117677417A (zh) * | 2021-07-08 | 2024-03-08 | 阿斯利康(瑞典)有限公司 | 用于吸入器使用的检测和分析的设备和系统 |
| US11951246B1 (en) * | 2023-09-27 | 2024-04-09 | Yale University | Systems and methods for coaching inhaler use via synchronizing patient and respiratory cycle behaviors |
| CN120215871B (zh) * | 2025-04-22 | 2025-11-11 | 阿斯利康药业(中国)有限公司 | 一种药物吸入器的语音提醒方法、语音设置方法及其系统 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE466684B (sv) * | 1989-03-07 | 1992-03-23 | Draco Ab | Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator |
| US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
| US5507277A (en) | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
| GB2398065A (en) * | 2003-10-16 | 2004-08-11 | Bespak Plc | Dispensing apparatus |
| US8361026B2 (en) | 2005-02-01 | 2013-01-29 | Intelliject, Inc. | Apparatus and methods for self-administration of vaccines and other medicaments |
| US8226610B2 (en) | 2005-02-01 | 2012-07-24 | Intelliject, Inc. | Medical injector with compliance tracking and monitoring |
| DE602006013636D1 (de) * | 2005-05-24 | 2010-05-27 | Letcat Ab | Dosiszähler |
| EP1993642B1 (en) * | 2006-03-07 | 2012-01-11 | Bang & Olufsen Medicom A/S | Acoustic inhaler flow measurement |
| US8060249B2 (en) | 2006-11-22 | 2011-11-15 | Senticare Inc. | Medication dispenser with integrated monitoring system |
| NZ574666A (en) | 2009-02-05 | 2009-04-30 | Nexus6 Ltd | A medicament inhaler holder that uses optical means to count and display the number of doses used |
| US20120116186A1 (en) * | 2009-07-20 | 2012-05-10 | University Of Florida Research Foundation, Inc. | Method and apparatus for evaluation of a subject's emotional, physiological and/or physical state with the subject's physiological and/or acoustic data |
| TWI633902B (zh) * | 2010-03-22 | 2018-09-01 | 賽諾菲阿凡提斯德意志有限公司 | 用於判定與醫療裝置有關的資訊之裝置、方法、系統及電腦程式 |
| GB201006901D0 (en) | 2010-04-26 | 2010-06-09 | Sagentia Ltd | Device for monitoring status and use of an inhalation or nasal drug delivery device |
| US20120265548A1 (en) | 2011-04-14 | 2012-10-18 | Searete Llc, A Limited Liability Corporation Of The Sate Of Delaware | Cost-effective resource apportionment technologies suitable for facilitating therapies |
| US8599009B2 (en) | 2011-08-16 | 2013-12-03 | Elwha Llc | Systematic distillation of status data relating to regimen compliance |
| JP6116570B2 (ja) * | 2011-09-08 | 2017-04-19 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬物送達デバイスの作動を監視するための方法及び監視デバイス |
| NZ595367A (en) | 2011-09-23 | 2012-02-24 | Nexus6 Ltd | A dose counting mechanism adapted to enclose a medicament delivery device |
-
2014
- 2014-07-11 CA CA2917443A patent/CA2917443A1/en not_active Abandoned
- 2014-07-11 EP EP14822383.7A patent/EP3019081A4/en not_active Withdrawn
- 2014-07-11 US US14/903,936 patent/US20160166766A1/en not_active Abandoned
- 2014-07-11 AU AU2014287059A patent/AU2014287059A1/en not_active Abandoned
- 2014-07-11 JP JP2016525809A patent/JP2016526471A/ja active Pending
- 2014-07-11 WO PCT/US2014/046367 patent/WO2015006701A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3019081A4 (en) | 2018-04-25 |
| WO2015006701A3 (en) | 2015-04-23 |
| US20160166766A1 (en) | 2016-06-16 |
| EP3019081A2 (en) | 2016-05-18 |
| AU2014287059A1 (en) | 2016-02-04 |
| WO2015006701A2 (en) | 2015-01-15 |
| JP2016526471A (ja) | 2016-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20160166766A1 (en) | Acoustic based drug delivery monitor | |
| US20160129182A1 (en) | Vibration sensor based drug delivery monitor | |
| US12128174B1 (en) | Devices and methods for using medicament devices | |
| US20240153610A1 (en) | Tracker module for monitoring the use of a respiratory device | |
| EP2976120B1 (en) | System and method for monitoring usage of a respiratory medication delivery device | |
| US11406786B2 (en) | Nebulizer monitoring device, system and method | |
| JP7005660B2 (ja) | エアロゾル噴霧システムの制御デバイス | |
| US20200345588A1 (en) | Monitor device for real time compliance instructions and user feedback and clinician communication | |
| JP3085586B2 (ja) | 患者と医療専門家にフィードバックを提供する情報処理能力を有する吸入器 | |
| US8807131B1 (en) | Compliance monitoring for asthma inhalers | |
| EP3843820B1 (en) | Respiratory system and method that monitors medication flow | |
| TWI625142B (zh) | 貼附泵訓練裝置 | |
| US20160325058A1 (en) | Systems and methods for managing pulmonary medication delivery | |
| JP7461374B2 (ja) | ネブライザ監視装置、システム、および方法 | |
| CA3145869A1 (en) | Drug delivery device with electronics and power management | |
| US20210393892A1 (en) | Inhaler system | |
| US12220524B2 (en) | Inhaler system | |
| US20250190863A1 (en) | Drug delivery device with electronics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20190711 |